RecallRadar

FDA Drug recall D-0627-2018

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches Rx Only NDC 68968-5552-3 Manufac…

On 2018-04-25 the FDA classified a Class II recall of Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches Rx Only NDC 68968-5552-3 Manufac… by Noven Pharmaceuticals, citing defective Delivery System: Out of specification for adhesive transfer.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0627-2018
ClassificationClass II
Statusterminated
Initiated2018-04-09
Published2018-04-25
Last updated2026-09-13 11:52 UTC
CompanyNoven Pharmaceuticals
DistributionUS

Product

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches Rx Only NDC 68968-5552-3 Manufactured for Noven Therapeutics, LLC., Miami, FL 33186 by Noven Pharmaceuticals, Inc. Miami, FL 33186 1-877-567-7857

Reason

Defective Delivery System: Out of specification for adhesive transfer.

Identifiers

ndc68968-5552-3
ndc68968-5553-3
ndc68968-5554-3
ndc68968-5555-3
code_infoLot #: 82237 Exp. May 31, 2018

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0627-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.